IL-33 Neutralization Suppresses Lupus Disease in Lupus-Prone Mice
- First Online:
IL-33 is a new member of the IL-1 family that plays a role in inflammation. In this study, we evaluated the potential of IL-33 inhibition as a treatment for systemic lupus erythematosus (SLE) using the lupus-prone model MRL/lpr mice and the underlying mechanisms of action. We treated mice with anti-mouse IL-33 antibody (anti-IL-33Ab) via intraperitoneal injection every other day from week 14 until week 20 for 6 weeks. A control group received the same amount of IgG control. Renal damage and mouse survival were compared. Cytokines, antibodies, immune complex, Tregs, myeloid-derived suppressor cells (MDSCs), and Th17 cells were also analyzed. Correlations between serum IL-33 and SLE disease activity index in human SLE were also investigated. MRL/lpr mice treated with anti-IL-33Ab showed reduced proteinuria and reduced serum anti-dsDNA levels. Nephritis, immune complex deposits, and the circulating antibodies and immune complex besides the mortality were significantly reduced by anti-IL-33Ab. Anti-IL-33Ab remarkably increased Tregs and MDSCs and reduced the Th17 cells and IL-1β, IL-6, and IL-17 levels in MRL/lpr mice. These results suggest that IL-33 inhibition may inhibit SLE via expansion of Tregs and MDSCs and inhibition of Th17 cells and proinflammatory responses, indicating that blockade of IL-33 has a protective effect on SLE.
KEY WORDSsystemic lupus erythematosus IL-33 myeloid-derived suppressor cells lupus-prone mice
- 9.Humrich, J.Y., H. Morbach, R. Undeutsch, P. Enghard, S. Rosenberger, O. Weigert, et al. 2010. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proceedings of the National Academy of Sciences of the United States of America 107: 204–209.PubMedCentralPubMedCrossRefGoogle Scholar
- 10.Trigunaite A, Khan A, Der E, Song A, Varikuti S, Jørgensen TN. Gr1(high) CD11b(+) cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice. Arthritis Rheum. 2013. doi:10.1002/art.38048.